The [1,25(OH)2D3] active form of vitamin D has been regarded as an immunosuppressive agent that alleviates the pathogenesis of IBD, which stimulates mainly IELs to secrete IL-10 and TGF-β1 and inhibits inflammation in experimental mouse models of IBD (50). Here, IL10 is linked to inflammatory bowel disease.